These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19017467)

  • 1. Variations in C-reactive protein, plasma free radicals and fibrinogen values in patients with osteoarthritis treated with Pycnogenol.
    Belcaro G; Cesarone MR; Errichi S; Zulli C; Errichi BM; Vinciguerra G; Ledda A; Di Renzo A; Stuard S; Dugall M; Pellegrini L; Gizzi G; Ippolito E; Ricci A; Cacchio M; Cipollone G; Ruffini I; Fano F; Hosoi M; Rohdewald P
    Redox Rep; 2008; 13(6):271-6. PubMed ID: 19017467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of osteoarthritis with Pycnogenol. The SVOS (San Valentino Osteo-arthrosis Study). Evaluation of signs, symptoms, physical performance and vascular aspects.
    Belcaro G; Cesarone MR; Errichi S; Zulli C; Errichi BM; Vinciguerra G; Ledda A; Di Renzo A; Stuard S; Dugall M; Pellegrini L; Errichi S; Gizzi G; Ippolito E; Ricci A; Cacchio M; Cipollone G; Ruffini I; Fano F; Hosoi M; Rohdewald P
    Phytother Res; 2008 Apr; 22(4):518-23. PubMed ID: 18386255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pine bark extract (Pycnogenol) on symptoms of knee osteoarthritis.
    Cisár P; Jány R; Waczulíková I; Sumegová K; Muchová J; Vojtassák J; Duraćková Z; Lisý M; Rohdewald P
    Phytother Res; 2008 Aug; 22(8):1087-92. PubMed ID: 18570266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress.
    Belcaro G; Dugall M; Ippolito E; Hu S; Saggino A; Feragalli B
    J Neurosurg Sci; 2015 Dec; 59(4):437-46. PubMed ID: 26635191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pycnogenol efficacy in the treatment of systemic lupus erythematosus patients.
    Stefanescu M; Matache C; Onu A; Tanaseanu S; Dragomir C; Constantinescu I; Schönlau F; Rohdewald P; Szegli G
    Phytother Res; 2001 Dec; 15(8):698-704. PubMed ID: 11746863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study.
    Enseleit F; Sudano I; Périat D; Winnik S; Wolfrum M; Flammer AJ; Fröhlich GM; Kaiser P; Hirt A; Haile SR; Krasniqi N; Matter CM; Uhlenhut K; Högger P; Neidhart M; Lüscher TF; Ruschitzka F; Noll G
    Eur Heart J; 2012 Jul; 33(13):1589-97. PubMed ID: 22240497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalization of cardiovascular risk factors in peri-menopausal women with Pycnogenol®.
    Luzzi R; Belcaro G; Hosoi M; Feragalli B; Cornelli U; Dugall M; Ledda A
    Minerva Ginecol; 2017 Feb; 69(1):29-34. PubMed ID: 28116886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplementation with Pycnogenol® improves signs and symptoms of menopausal transition.
    Errichi S; Bottari A; Belcaro G; Cesarone MR; Hosoi M; Cornelli U; Dugall M; Ledda A; Feragalli B
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):65-70. PubMed ID: 22108479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pycnogenol®: supplementary management of symptomatic osteoarthritis with a patch. An observational registry study.
    Feragalli B; Dugall M; Luzzi R; Ledda A; Hosoi M; Belcaro G; Cesarone MR
    Minerva Endocrinol; 2019 Mar; 44(1):97-101. PubMed ID: 30561176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in signs and symptoms in psoriasis patients with Pycnogenol® supplementation.
    Belcaro G; Luzzi R; Hu S; Cesarone MR; Dugall M; Ippolito E; Corsi M; Caporale S
    Panminerva Med; 2014 Mar; 56(1):41-8. PubMed ID: 24637472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pycnogenol may alleviate adverse effects in oncologic treatment.
    Belcaro G; Cesarone MR; Genovesi D; Ledda A; Vinciguerra G; Ricci A; Pellegrini L; Gizzi G; Ippolito E; Dugall M; Cacchio M; Di Renzo A; Stuard S
    Panminerva Med; 2008 Sep; 50(3):227-34. PubMed ID: 18927527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
    de Maat MP; Madsen JS; Langdahl B; Bladbjerg EM; Tofteng CL; Abrahamsen B; Rejnmark L; Brixen K; Christensen K; Jespersen J; Kristensen SR
    Thromb Haemost; 2007 Feb; 97(2):234-9. PubMed ID: 17264952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pycnogenol® improves cognitive function, attention, mental performance and specific professional skills in healthy professionals aged 35-55.
    Belcaro G; Luzzi R; Dugall M; Ippolito E; Saggino A
    J Neurosurg Sci; 2014 Dec; 58(4):239-48. PubMed ID: 24675223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pycnogenol® improvements in asthma management.
    Belcaro G; Luzzi R; Cesinaro Di Rocco P; Cesarone MR; Dugall M; Feragalli B; Errichi BM; Ippolito E; Grossi MG; Hosoi M; Errichi S; Cornelli U; Ledda A; Gizzi G
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):57-64. PubMed ID: 22108478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of plasma fibrinogen levels by ticlopidine in healthy volunteers and patients with stable angina pectoris.
    de Maat MP; Arnold AE; van Buuren S; Wilson JH; Kluft C
    Thromb Haemost; 1996 Aug; 76(2):166-70. PubMed ID: 8865524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group.
    Altman RD; Moskowitz R
    J Rheumatol; 1998 Nov; 25(11):2203-12. PubMed ID: 9818665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PYCNOGENOL in chronic venous insufficiency.
    Petrassi C; Mastromarino A; Spartera C
    Phytomedicine; 2000 Oct; 7(5):383-8. PubMed ID: 11081989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of advanced glycation end-products inhibitor in osteoarthritis: a randomized, double-blind, placebo-controlled study.
    Garg S; Syngle A; Vohra K
    Clin J Pain; 2013 Aug; 29(8):717-24. PubMed ID: 23354008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study.
    Macin SM; Perna ER; Farías EF; Franciosi V; Cialzeta JR; Brizuela M; Medina F; Tajer C; Doval H; Badaracco R
    Am Heart J; 2005 Mar; 149(3):451-7. PubMed ID: 15864233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic myalgic pain (fibromyalgia): supportive management and prevention with Pycnogenol®.
    Belcaro G; Hu S; Cesarone MR; Dugall M; Scipione C; Scipione V; Hosoi M; Ledda A; Cornelli U; Feragalli B; Cotellese R
    Panminerva Med; 2021 Mar; 63(1):46-50. PubMed ID: 33541059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.